Filter
168
Filtered Results: 168
Text search:
enzyme
immunoassays
Featured
Recommendations
28
New Publications
70
Language
Document type
No document type
94
Guidelines
42
Studies & Reports
15
Manuals
7
Fact sheets
5
Strategic & Response Plan
3
Training Material
2
Countries / Regions
India
12
Global
6
Latin America and the Carribbean
4
South Africa
4
Colombia
3
Philippines
3
Germany
3
Bangladesh
3
Indonesia
3
Nepal
2
Ghana
2
Sierra Leone
2
Rwanda
2
Peru
2
Malawi
2
Western and Central Europe
2
North America
2
Brazil
2
Zambia
2
North Macedonia
1
Kenya
1
Lesotho
1
Cameroon
1
Nigeria
1
Mozambique
1
USA
1
Africa
1
Venezuela
1
Tanzania
1
Southern Africa
1
Bolivia
1
Uganda
1
Namibia
1
Ethiopia
1
Angola
1
Ecuador
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Guidelines
20
Policies & Guidelines HIV & TB
12
Demograhic Health Surveys DHS
9
Studies & Reports
8
HIV & STI
8
Hepatitis
7
COVID-19
6
Disease Prevention & Control
6
General Guidelines
5
Vaccine-preventable Diseases
5
Chagas
5
NTDs & Others
4
Virology
3
Policies
3
Communicable Diseases
3
TB
3
Bacteriology
2
Infection Control & Prevention (IPC)
2
Snakebites
2
Yersinia pestis (Plague)
2
Yellow Fever
2
Capacity Building
2
Dengue
2
Non-communicable Diseases
2
Zika
1
Hematology
1
Vector Control
1
Pediatrics
1
Medical Devices & Equipment
1
Clinical Guidelines
1
Drugs & Medical Equipment
1
Women & Child Health
1
Information, Education and Communication (IEC)
1
Quality Control & Assurance
1
Health Systems
1
Laboratory Quality Assurance
1
Toolboxes
Laboratory
9
Testing Guidelines
9
HIV testing & services
7
Clinical Aspects
6
Surveillance
5
Diagnostics & Laboratory Guidance
5
Clinical Aspects, Treatment & Prevention
4
Public Health
4
Vaxzevria (Astra Zeneca)
4
Overview, Studies & Reports
4
Influenza Prevention & Control
3
HIV surveillance
3
Treatment Guidelines HIV
3
Clinical Guidelines
3
Country specific documents
3
Antiretroviral Treatment ART
3
Plague Prevention & Control
3
Yellow Fever Prevention & Control
2
Opportunistic Infections
2
Hepatitis
2
Context & Facts, Travel Advice
2
Surveillance & Contact tracing
2
One Health
2
Chagas
2
Access to treatment and laboratory
2
Health Worker
2
TB & Prisoners
2
Prisoners
2
Behaviour Change/Life Skill Education
1
ART Drug Resistance
1
Surveillance
1
Agriculture & Veterinary
1
Yellow Fever
1
Country specific
1
Prevention & Control
1
Key Resources
1
Adults
1
Plague
1
Prevention Guidelines
1
Dengue
1
Policies
1
HIV testing & disclosure
1
Sexually Transmitted Infections
1
Laboratory & Sampling
1
Medical professionals
1
Climate & Health
1
Context & Facts
1
Treatment Guidelines
1
Prevention & Preparedness
1
Clinical Aspects
1
Infection Control General
1
Training, others
1
Clinical Guidelines
1
Human Rights
1
Scientific & Research Studies
1
Paediatrics
1
Physical Distancing
1
Immunization Guidelines
1
Non-pharmaceutical interventions (NPIs)
1
Biontech/Pfizer Comirnaty
1
Essential Medicines
1
Essential Medicines & Devices Lists
1
Quality Assurance
1
General documents One Health
1
General Guidelines for Rational Use
1
Pharmaceutical Dosage Forms
1
Infectious Diseases
1
Health Impact & Climate Change
1
MOPX - Monkeypox
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Vector control
1
Snakebite envenoming
1
Detection & Diagnosis
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Co-Morbidities (except TB)
1
Prevention of mother-to-child transmission (PMTCT)
1
Dengue Prevention & Control
1
Latin America & the Carribean
1
Clinical Guidelines
1
HIV and coinfection
1
TB/HIV Coinfection
1
Zika Prevention & Control
1
Others
1
Infection Control
1
HIV in Key Populations
1
Preparedness & Prevention
1
Laboratory & Diagnostics
1
Reports & Studies
1
Eastern and Southern Africa
1
Eastern Europe and central Asia
1
This manual describes some of the strategic, managerial, financial, technical and scientific aspects to be considered in establishing a national EQA programme for clinical laboratories and other testing services at all health care levels
Advance copy.
PQDx 0144-043-00 WHO
PQDx Public Report
November/2016, version 4.0
PQDx 0214-064-00
WHO PQDx PR
April/2016, version 3.0
PQDx 0183‐060‐00 WHO
PQ Public Report
October/2016, version 5.0
PQDx 0006-005-00 WHO
PQDx PR
February/2016, version 2.0
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
PQDx 0198-071-00
WHO PQDx PR
April/2016, version 2.0
HIV testing
Policy Brief
July 2015
WHO recommends replacing western blotting and line immunoassays with simpler tests in HIV testing services. These simpler tests include rapid diagnostic tests (RDTs) that can be used at the point-of-care, and enzyme immunoassays (EIAs).
These tests get results to the client faster, produce accura...
Policy brief. HIV testing services (HTS) and anti-retroviral therapy (ART) have been scaled up substantially. It is estimated that, globally, nearly 80% of people with HIV now know their status. With the offer of immediate ART initiation and improved treatment options, access to and uptake of treatm...
Policy Brief.
WHO recommends that pregnant women receive testing for HIV, syphilis and hepatitis B (HBSAg) at least once during pregnancy, preferably in the first trimester.
Dual HIV/syphilis rapid diagnostic tests (RDTs) can be used as the first test for pregnant women as part of antenatal care (...
This report investigates the impact of potential misclassification of samples on HIV prevalence estimates for 23 surveys conducted from 2010-2014. In addition to visual inspection of laboratory results, we examined how accounting for potential misclassification of HIV status through Bayesian latent ...
Eaton JW et al. Journal of the International AIDS Society 2019, 22(S1):e25237 http://onlinelibrary.wiley.com/doi/10.1002/jia2.25237/full | https://doi.org/10.1002/jia2.25237
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t...
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera...
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
New England Journal of Medicine
April 9, 2021
DOI: 10.1056/NEJMoa2104840
